Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia.

Cerebral amyloid angiopathy (CAA) is the common term used to define the deposition of amyloid in the walls of medium- and small-size leptomeningeal and cortical arteries, arterioles and, less frequently, capillaries and veins. CAA is an important cause of cerebral hemorrhages although it may also lead to ischemic infarction and dementia. It is a feature commonly associated with normal aging, Alzheimer disease (AD), Down syndrome (DS), and Sporadic Cerebral Amyloid Angiopathy. Familial conditions in which amyloid is chiefly deposited as CAA include hereditary cerebral hemorrhage with amyloidosis of Icelandic type (HCHWA-I), familial CAA related to Abeta variants, including hereditary cerebral hemorrhage with amyloidosis of Dutch origin (HCHWA-D), the transthyretin-related meningocerebrovascular amyloidosis of Hungarian and Ohio kindreds, the gelsolin-related spinal and cerebral amyloid angiopathy, familial PrP-CAA, and the recently described chromosome 13 familial dementia in British and Danish kindreds. This review focuses on the various molecules and genetic variants that target the cerebral vessel walls producing clinical features related to stroke and/or dementia, and discusses the potential role of amyloid in the mechanism of neurodegeneration.

[1]  D. Craik,et al.  Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis. , 1994, European journal of biochemistry.

[2]  H. Mantsch,et al.  Comparative Analysis of Human and Dutch-Type Alzheimer β-Amyloid Peptides by Infrared Spectroscopy and Circular Dichroism , 1993 .

[3]  P. George-Hyslop.  Molecular genetics of Alzheimer disease. , 1999 .

[4]  D. Premkumar,et al.  Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. , 1996, Brain research. Molecular brain research.

[5]  Ó. Jensson,et al.  causing amyloid angiopathy and brain hemorrhage ‐ clinical genetics in Iceland , 1989, Clinical genetics.

[6]  C. López-Otín,et al.  Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases , 1989, The Journal of experimental medicine.

[7]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[8]  E. Wijsman,et al.  Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. , 1992, American journal of human genetics.

[9]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.

[10]  S. Mead,et al.  Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings. , 2000, Brain : a journal of neurology.

[11]  D. Selkoe,et al.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.

[12]  G. Bots,et al.  Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy , 1988, Journal of the Neurological Sciences.

[13]  Jon Thorgeir Hallgrimsson,et al.  HEREDITARY CEREBRAL HEMORRHAGE WITH AMYLOIDOSIS , 1972 .

[14]  T Bek,et al.  A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Markesbery,et al.  N‐terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits , 1998, Journal of neuropathology and experimental neurology.

[16]  S. Kiuru.  Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[17]  J. Holton,et al.  Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation , 1999, Acta Neuropathologica.

[18]  H. Budka,et al.  Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G) , 1996, The American journal of pathology.

[19]  Agueda Rostagno,et al.  A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.

[20]  B. Frangione,et al.  Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace , 1983, The Journal of experimental medicine.

[21]  B. Ghetti,et al.  Neurofibrillary tangles of the Indiana kindred of Gerstmann-Stra¨ussler-Scheinker disease share antigenic determinants with those of Alzheimer disease , 1990, Brain Research.

[22]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Selkoe,et al.  Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[24]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Barrett,et al.  Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. , 1986, The Journal of biological chemistry.

[26]  G. Glenner,et al.  Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease , 1988, Journal of neurochemistry.

[27]  T. Iwatsubo,et al.  Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain , 1996, Neuroscience Letters.

[28]  J. Ghiso,et al.  Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. , 1990, The Biochemical journal.

[29]  J. Ghiso,et al.  Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[31]  D. Selkoe,et al.  Nomenclature of amyloid fibril proteins. Report from the meeting of the98. Part 1 [editorial] , 1999 .

[32]  Molecular genetics of Alzheimer’s disease , 2000, Biological Psychiatry.

[33]  D. Walsh,et al.  Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide , 1993, Neuroscience Letters.

[34]  D. Dickson,et al.  Neurodegenerative diseases with cytoskeletal pathology: A biochemical classification , 1997, Annals of neurology.

[35]  W. Luyendijk,et al.  INTRACEREBRAL HEMATOMAS. A CLINICAL STUDY OF 40 SURGICAL CASES. , 1964, Psychiatria, neurologia, neurochirurgia.

[36]  G. Plant,et al.  Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. , 1990, Brain : a journal of neurology.

[37]  C. Worster-Drought,et al.  Familial Presenile Dementia with Spastic Paralysis* , 1933, The Journal of neurology and psychopathology.

[38]  H. Vinters.  Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.

[39]  S. V. van Duinen,et al.  Expression of a normal and variant Alzheimer's beta-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays. , 1990, Biochemical and biophysical research communications.

[40]  J. Ghiso,et al.  Mutation in gelsolin gene in Finnish hereditary amyloidosis , 1990, The Journal of experimental medicine.

[41]  T. Wisniewski,et al.  Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. , 1991, Biochemical and biophysical research communications.

[42]  A. Hofman,et al.  Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene , 1992, Nature Genetics.

[43]  Claudio Soto,et al.  β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy , 1998, Nature Medicine.

[44]  J. Kere,et al.  Familial amyloidosis, Finnish type: G654----a mutation of the gelsolin gene in Finnish families and an unrelated American family. , 1992, Genomics.

[45]  S. V. van Duinen,et al.  Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Wisniewski,et al.  Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. , 1995, The Biochemical journal.

[47]  R. Mohs,et al.  Cerebral infarcts in patients with autopsy-proven Alzheimer's disease , 1998, Neurology.

[48]  D. Geschwind,et al.  Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. Petersen,et al.  Transthyretin amyloidosis: A new mutation associated with dementia , 1997, Annals of neurology.

[50]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[51]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[52]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[53]  K. Pittois,et al.  cDNA sequence analysis, chromosomal assignment and expression pattern of the gene coding for integral membrane protein 2B. , 1998, Gene.

[54]  J. Meretoja.  Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. , 1969, Annals of clinical research.

[55]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[56]  C. Maury,et al.  Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. , 1990, Biochimica et biophysica acta.

[57]  G. Gudmundsson,et al.  Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis. , 1984, The New England journal of medicine.

[58]  O. Salonen,et al.  Gelsolin‐related spinal and cerebral amyloid angiopathy , 1999, Annals of neurology.

[59]  G. Bots,et al.  Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage , 1982, Journal of the Neurological Sciences.

[60]  B. Ghetti,et al.  Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.